Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Extreme Networks, Inc. for alleged misleading statements about its business performance, particularly concerning backlog orders and revenue projections. Investors who suffered losses exceeding $100,000 in Extreme Networks between July 27, 2022 and January 30, 2024 are encouraged to contact the firm to discuss their options.
Faruqi & Faruqi, LLP, a prominent securities law firm, is investigating potential legal claims against Nano Nuclear Energy Inc. (NNE) on behalf of investors who suffered losses exceeding $50,000 between May 8, 2024, and July 18, 2024. The investigation centers around allegations that NNE made misleading statements about its progress and capabilities, potentially impacting investor confidence and leading to stock price decline.
Faruqi & Faruqi, LLP, a prominent national securities law firm, is investigating possible claims against Sprinklr, Inc. The firm is looking into allegations that the company made misleading statements concerning its growth prospects, leading to significant losses for investors. The investigation focuses on Sprinklr’s struggles in the Contact Center as a Service market, its reduced growth estimates, and the impact on its stock price.
Faruqi & Faruqi, LLP, a securities law firm, is investigating potential claims against Vicor Corporation (VICR) for alleged false and misleading statements. The firm is seeking investors who suffered losses exceeding $100,000 in Vicor between April 26, 2023 and February 22, 2024 to contact them directly to discuss their options.
Faruqi & Faruqi, LLP, a leading securities law firm, is investigating potential claims against DexCom, Inc. The firm alleges that DexCom misled investors about its salesforce’s ability to meet growth expectations. Following a significant drop in stock price after DexCom announced reduced revenue guidance, investors who suffered losses exceeding $100,000 are encouraged to contact the firm.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation (Global Cord or the Company) following allegations of material misstatements regarding the company’s business operations and prospects. The investigation focuses on the period between June 4, 2019, and May 3, 2022, and encourages investors who suffered losses exceeding $75,000 to contact the firm. The firm believes that Global Cord’s public statements during this time were materially false and misleading, and that the company’s decisions were made to benefit insiders and related parties rather than shareholders.
